Timing and Intrauterine Insemination in Unexplained Infertility

NCTNCT03920514Other idIntrauterine insemination

Open at ClinicalTrials.govAsk about this trial

Overview

Status: Status unknown
Phase: Phase 4
Enrollment: 80 participants (estimated)
Sponsor: Sohag University · Other
Design: Randomized · Single masking
Countries: Not stated
Start: 30 Apr 2019 (estimated)
Primary completion: 30 Sept 2019 (estimated)
Completion: 31 Dec 2019 (estimated)
First posted: 19 Apr 2019
Last update posted: 19 Apr 2019
Conditions: Intrauterine Insemination

Timeline

1 trial

Completed
Ongoing
Not yet recruiting
Stopped
Estimated dates (est.)
Results posted

20192020

Ph 4
Timing and Intrauterine Insemination in Unexplained Infertility
NCT03920514
est. 30 Apr 2019 to est. 31 Dec 2019

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

to determine the most suitable time for administration of (human chorionic gonadotropin )hCG prior to intrauterine insemination (IUI) to optimize pregnancy outcome and to have the best success rates so the cases divided in to four groups according to the time of hCG administration .

Interventions

hCGDrug

Arms4

Active comparator
GROUP 1
IUI 24 hours after hCGadminstration
Active comparator
GROUP 2
IUI 36 hours after hCG adminstration
Active comparator
GROUP 3
IUI 48 hours after hCG adminstration
Active comparator
GROUP 4
IUI at time of hCG adminstration

Primary outcomes2

Outcomes the sponsor listed as primary.

Primary outcome
Time frame · 14 days after IUI
Registry description
Positive serum beta hCG test
Secondary outcome
Time frame · 4 weeks after insemination
Registry description
Clinical pregnancy defined as prescence of at least one Intrauterine gestational sac with fetal pole on Transvaginal scan

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

A trial that is still running, or that stopped early, may post results later.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Eligibility

Who could join, as posted.

Sex: Female
Age: from 18 Years up to 40 Years
Healthy volunteers: Not accepted

Inclusion and exclusion criteria, as posted

Inclusion Criteria: * Mild male infertility or unexplained infertility Exclusion Criteria: * Adanced male factor endometriosis uterine abnormality sever semen parameters i impairment according to WHO 2010 non ovulatory cycles bilatral tubal block

PepBank is a research reference. Talk to a doctor before you use any peptide.